Since TREM2 plays a relevant role in microglial function during the development of AD (Guerreiro et al. 2013; Ulland and Colonna 2018), our findings suggest that modulating microglial immunological memory may be a promising strategy for controlling their function. The gene discussed is TREM2; the disease is Alzheimer disease.